---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-292501"
form_type: "8-K"
ticker: "SGMO"
cik: "0001001233"
company_name: "SANGAMO THERAPEUTICS, INC"
filed_at: "2026-07-01T20:01:16+00:00"
generated_at: "2026-07-01T20:03:05.397554+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Sangamo Therapeutics files Chapter 11; stock now trades on OTCID Basic under SGMOQ; auditor EY terminated

## Summary
- Filed voluntary Chapter 11 petition (Case No. 26-10989) on June 24, 2026.
- Common stock began trading on OTCID Basic Market under symbol SGMOQ on June 24, 2026.
- Nasdaq delisting appeal pending; stock suspended from Nasdaq since May 5, 2026.
- Audit committee terminated Ernst & Young as independent auditor on June 25, 2026.
- No new auditor engaged; EY's reports included going-concern explanatory paragraph.

## SEC filing metadata
- accession: 0001193125-26-292501
- form_type: 8-K
- ticker: SGMO
- cik: 0001001233
- company_name: SANGAMO THERAPEUTICS, INC
- filed_at: 2026-07-01T20:01:16+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 4.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001233/000119312526292501/0001193125-26-292501-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001233/000119312526292501/d113173d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-292501
- JSON: https://secwatch.observer/filing/0001193125-26-292501.json
- Plain text: https://secwatch.observer/filing/0001193125-26-292501.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.